Iris International, Inc. (MM) (IRIS) Cotización

Got my hopes up.

Nice

~ Wednesday! $IRIS ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!

~ $IRIS ~ Earnings expected on Wednesday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=IRIS&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=IRIS&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=IRIS
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=IRIS#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=IRIS+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=IRIS
Finviz: http://finviz.com/quote.ashx?t=IRIS
~ BusyStock: http://busystock.com/i.php?s=IRIS&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=IRIS >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

IRIS International, Inc. manufactures automated in-vitro diagnostics (IVD) for use in hospitals and commercial laboratories worldwide and also provides personalized diagnostics testing services through a molecular diagnostics laboratory. The Company offers products that analyze particles and living cell forms and structures, or morphology of a variety of body fluids. It provides automated urine microscopy systems, with approximately 3,000 systems sold in over 50 countries. The Company also provide integrated solutions comprising urine microscopy and urine chemistry products as well as consumable supplies, system support services and sample preparation products. It has research and development platform in molecular diagnostics based on its Nucleic Acid Detection Immunoassay (NADiA), which it develops for various applications in personalized diagnostics for oncology.

http://www.google.com/finance?q=IRIS